Suppr超能文献

[高剂量吸入性皮质激素疗法治疗哮喘的作用机制及给药方式]

[Mechanism of action and mode of administration of high-dose inhaled corticotherapy in the treatment of asthma].

作者信息

Tenabene A, Dietemann-Molard A, Kapps M, Pauli G

机构信息

Service de Pneumologie II, Pavillon Laennec, CHRU de Strasbourg.

出版信息

Rev Pneumol Clin. 1988;44(6):273-7.

PMID:3072652
Abstract

The commercial availability of high-dose inhaled corticosteroid preparations for the treatment of asthma offers an occasion for reviewing the different mechanisms of action of glucocorticoids notably glucocorticoids, notably their interference with lipocortin protein synthesis and arachidonic acid metabolism. A favourable effect on bronchial hyper-reactivity and on delayed hypersensitivity reactions has also been observed. The problems raised by the various preparations responsible for varying degrees of systemic activity, the difficulties inherent in the use of inhalers and the side-effects of these products are discussed. The effectiveness and safety of the current high-dose inhaled preparations are emphasized.

摘要

用于治疗哮喘的高剂量吸入性皮质类固醇制剂的商业可得性,为回顾糖皮质激素的不同作用机制提供了契机,尤其是糖皮质激素对脂皮质素蛋白合成和花生四烯酸代谢的干扰。人们还观察到其对支气管高反应性和迟发型超敏反应有有利影响。文中讨论了各种制剂因全身活性程度不同而引发的问题、吸入器使用中固有的困难以及这些产品的副作用。强调了当前高剂量吸入制剂的有效性和安全性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验